Yan Liu - China Jo Secretary
| CJJD Stock | USD 2.01 0.02 0.99% |
Executive
Mr. Yan Liu is Secretary of the Company. from August 15, 2017 to August 1, 2018, Mr. Liu had been a project manager with Ping An Insurance Company of China, Ltd., a Chinese holding conglomerate whose subsidiaries mainly deal with insurance, banking, and financial services. Ping An Insurance is one of the top 50 companies on the Shanghai Stock Exchange. While at Ping An Insurance, Mr. Liu was mainly responsible for projects dealing with the reformation of the current Chinese medical system and market, which is a US1.3 trillion industry as of 2018. Prior to that Mr. Liu had served as Director of Investor Relations for the Company from 2015 since 2018.
| Age | 34 |
| Tenure | 6 years |
| Address | Building 5, Hangzhou, China, 310008 |
| Phone | 86 57 1882 19579 |
| Web | https://www.jiuzhou360.com |
China Jo Management Efficiency
The company has return on total asset (ROA) of (0.0238) % which means that it has lost $0.0238 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2735) %, meaning that it created substantial loss on money invested by shareholders. China Jo's management efficiency ratios could be used to measure how well China Jo manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to 4.00, whereas Return On Tangible Assets are forecasted to decline to (17.90). At present, China Jo's Other Assets are projected to decrease significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 3.8 M, whereas Total Current Assets are forecasted to decline to about 47.9 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Theresa Mota | SunLink Health Systems | N/A | |
| Robyn DElia | PetMed Express | N/A | |
| Jacqueline Smith | PetMed Express | N/A | |
| Lanesha JD | Walgreens Boots Alliance | 49 | |
| Neal Sample | Walgreens Boots Alliance | 49 | |
| Omar Khan | High Tide | N/A | |
| Caroline Conegliano | PetMed Express | N/A | |
| James Mulligan | SunLink Health Systems | 102 | |
| Gerald Gradwell | Walgreens Boots Alliance | 56 | |
| Lanesha Minnix | Walgreens Boots Alliance | 49 | |
| Umesh Sripad | PetMed Express | N/A | |
| Rick Gates | Walgreens Boots Alliance | 53 | |
| Sandy Sharma | High Tide | N/A | |
| Natasha Polster | Walgreens Boots Alliance | N/A | |
| John Driscoll | Walgreens Boots Alliance | 65 | |
| Elizabeth Burger | Walgreens Boots Alliance | 53 | |
| CPA CMA | High Tide | N/A | |
| Shimshon JD | High Tide | N/A | |
| Tiffany Kanaga | Walgreens Boots Alliance | N/A | |
| Liyue Wu | Walgreens Boots Alliance | N/A | |
| Beth Leonard | Walgreens Boots Alliance | N/A | |
Management Performance
| Return On Equity | -0.27 | ||||
| Return On Asset | -0.0238 |
China Jo Jo Leadership Team
Elected by the shareholders, the China Jo's board of directors comprises two types of representatives: China Jo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Jo's management team and ensure that shareholders' interests are well served. China Jo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Jo's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yan Liu, Secretary | ||
| Lei Liu, Chairman of the Board, CEO | ||
| Steve Liu, Investor Director | ||
| Lei MD, Chairman CEO | ||
| Ming Zhao, Chief Officer |
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is China Jo a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.27 | ||||
| Return On Asset | -0.0238 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | (0.05) % | ||||
| Current Valuation | 35.51 M | ||||
| Shares Outstanding | 6.18 M | ||||
| Shares Owned By Insiders | 38.34 % | ||||
| Shares Owned By Institutions | 0.31 % | ||||
| Number Of Shares Shorted | 30.24 K | ||||
| Price To Earning | (4.60) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether China Jo Jo is a strong investment it is important to analyze China Jo's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact China Jo's future performance. For an informed investment choice regarding China Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Jo Jo Drugstores. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China Jo. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China Jo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.93) | Revenue Per Share 107.003 | Quarterly Revenue Growth (0) | Return On Assets (0.02) | Return On Equity (0.27) |
The market value of China Jo Jo is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China Jo's value that differs from its market value or its book value, called intrinsic value, which is China Jo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China Jo's market value can be influenced by many factors that don't directly affect China Jo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China Jo's value and its price as these two are different measures arrived at by different means. Investors typically determine if China Jo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China Jo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.